[1]
Albareda, N., Rosenberg, N., Roth, S., Zsolt, I., Rosen, T. and Hebert, A.A. 2017. Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Phase III Clinical Trials Pooled Analysis Results. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s102. DOI:https://doi.org/10.25251/skin.1.supp.101.